Effects of an angiotensin–converting–enzyme inhibitor, ramipril, on cardiovascular events in high–risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. - Yusuf,S.; Sleight,P.; Pogue,J. (N Engl J Med, 2000)